Who Owns Milestone Pharmaceuticals Stock?
NASDAQ: MISTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 51.49%
- Held by insiders
- 0.70%
- Institutional holders
- 88
- Institutions 51.5%
- Insiders 0.7%
- Public and other 47.8%
Who owns Milestone Pharmaceuticals stock?
Institutional investors own about 51.5% of Milestone Pharmaceuticals's shares, spread across 88 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.70% of MIST.
The largest institutional holders are Pavaki Capital Management LLC (7.28%), RTW Investments LP (6.29%) and Propel Bio Management, LLC (5.97%). Together, the top 10 institutions control 34.1% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their MIST positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MIST
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Pavaki Capital Management LLC | 9.07M | 7.28% | +0.1% |
| RTW Investments LP | 7.83M | 6.29% | +23.7% |
| Propel Bio Management, LLC | 7.43M | 5.97% | +80.4% |
| Point72 Asset Management, L.P. | 5.41M | 4.35% | +398.4% |
| Simplify Asset Management, Inc. | 3.35M | 2.69% | +122.3% |
| Millennium Management Llc | 3.14M | 2.52% | +103.5% |
| Two Sigma Investments, LP | 2.04M | 1.64% | -12.0% |
| Marshall Wace LLP | 1.80M | 1.44% | -7.5% |
| Kalehua Capital Management LLC | 1.27M | 1.02% | +100.0% |
| RVW Wealth, LLC | 1.15M | 0.92% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MIST
| Fund | Shares | % Held |
|---|---|---|
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 3.35M | 2.69% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 69.43K | 0.06% |
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF | 22.68K | 0.02% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 11.00K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Milestone Pharmaceuticals?
Pavaki Capital Management LLC is the largest institutional shareholder of MIST, owning 7.28% of shares outstanding (9.07M shares) as of its latest 13F filing.
What percentage of Milestone Pharmaceuticals is owned by institutions?
Institutions own about 51.5% of MIST shares and 51.8% of the public float.
How much of Milestone Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.70% of MIST shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.